IL-10 Signaling Elicited by Nivolumab-Induced Activation of the MAP Kinase Pathway Does Not Fully Contribute to Nivolumab-Modulated Heterogeneous T Cell ResponsesTaylor Harper, Gerald M. Feldman|International Journal of Molecular Sciences|2021Cited by 8